ReWalk Robotics Ltd Stock News

Accuray (ARAY) delivered earnings and revenue surprises of 83.33% and 3.35%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Seasoned Medical Device professional brings 25 years of experience in commercializing novel technologies and in new business development Seasoned Medical Device professional brings 25 years of experie

US crude oil futures traded lower on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the co

Simon Kindleysides is first paralyzed man to climb a 51-story skyscraper; earns his second Guinness World Record using his ReWalk Personal Exoskeleton Simon Kindleysides is first paralyzed man to clim

ReWalk just barely met its 2021 revenue targets at $6 million for the year, but was still dealing with Covid-19 restrictions impacting the sales process for much of the year.

ReWalk Robotics Ltd. (RWLK) CEO Larry Jasinki on Q4 2021 Results - Earnings Call Transcript

We have also developed and began commercializing our ReStore device in June 2019. The Company will be the exclusive distributor of the MediTouch Tutor movement biofeedback systems in the United States and will also have distribution rights for the MYOLYN MyoCycle FES cycles to U.S. rehabilitation clinics and personal sales through the U.S. Department of… The post REWALK ROBOTICS LTD. – 10-K – MANAGEMENT''S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS appeared first on InsuranceNewsNet .

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Feb. 21, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company wil

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Feb. 21, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will

ReWalk (RWLK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research lowered shares of ReWalk Robotics (NASDAQ:RWLK) from a buy rating to a hold rating in a report issued on Tuesday, Zacks.com reports. According to Zacks, ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with spinal cord injury. The Companys exoskeletons allow wheelchair-bound individuals with mobility impairments or other []

ReWalk Robotics Ltd. (NASDAQ:RWLK) was the target of a significant decline in short interest during the month of November. As of November 30th, there was short interest totalling 2,560,000 shares, a decline of 37.9% from the November 15th total of 4,120,000 shares. Based on an average daily trading volume, of 15,970,000 shares, the days-to-cover ratio [] The post ReWalk Robotics Ltd. (NASDAQ:RWLK) Short Interest Down 37.9% in November appeared first on ETF Daily News .

ReWalk Robotics Ltd. (NASDAQ:RWLK) was the recipient of a large drop in short interest in the month of November. As of November 30th, there was short interest totalling 2,560,000 shares, a drop of 37.9% from the November 15th total of 4,120,000 shares. Based on an average daily trading volume, of 15,970,000 shares, the short-interest ratio […]